D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 69 Citations 38,340 131 World Ranking 1602 National Ranking 791

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Immune system

John R. Wunderlich spends much of his time researching Immunology, Melanoma, Adoptive cell transfer, Antigen and Immunotherapy. John R. Wunderlich regularly links together related areas like Cancer research in his Immunology studies. He focuses mostly in the field of Melanoma, narrowing it down to matters related to Cancer and, in some cases, Peptide vaccine.

In his research on the topic of Adoptive cell transfer, Tumor antigen is strongly related with Tumor-infiltrating lymphocytes. His Antigen study combines topics in areas such as Tumor microenvironment, Cancer immunotherapy and T-cell receptor. His Immunotherapy research incorporates themes from Interleukin 2 and Lymphocyte.

His most cited work include:

  • Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (2452 citations)
  • Cancer regression in patients after transfer of genetically engineered lymphocytes (2174 citations)
  • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma (1702 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Immunology, Melanoma, Antigen, Immunotherapy and Cancer research. He works mostly in the field of Immunology, limiting it down to concerns involving Cytotoxic T cell and, occasionally, Molecular biology and Cytokine. The study incorporates disciplines such as Cancer, Internal medicine, Oncology, Pathology and Peripheral blood mononuclear cell in addition to Melanoma.

The various areas that John R. Wunderlich examines in his Antigen study include Tumor antigen and T-cell receptor. His Immunotherapy study which covers Cell therapy that intersects with Clinical trial. His Cancer research research is multidisciplinary, relying on both Mutation, Cell growth and Somatic cell.

He most often published in these fields:

  • Immunology (54.41%)
  • Melanoma (38.97%)
  • Antigen (36.76%)

What were the highlights of his more recent work (between 2012-2019)?

  • Immunology (54.41%)
  • Cancer research (28.68%)
  • Melanoma (38.97%)

In recent papers he was focusing on the following fields of study:

John R. Wunderlich mainly investigates Immunology, Cancer research, Melanoma, Cancer and Adoptive cell transfer. His Immunology research includes themes of Receptor and Chemotherapy. His work carried out in the field of Chemotherapy brings together such families of science as Cytotoxic T cell and Tumor-infiltrating lymphocytes.

His biological study deals with issues like Pathology, which deal with fields such as Cancer treatment. The concepts of his Cancer study are interwoven with issues in Lesion and Disease. John R. Wunderlich interconnects CD137 and Human papillomavirus in the investigation of issues within Adoptive cell transfer.

Between 2012 and 2019, his most popular works were:

  • Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. (989 citations)
  • PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors (585 citations)
  • Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients (465 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Immune system

John R. Wunderlich focuses on Immunology, Immunotherapy, Melanoma, Antigen and Adoptive cell transfer. In his work, John R. Wunderlich performs multidisciplinary research in Melanoma and Response Evaluation Criteria in Solid Tumors. His Antigen study combines topics from a wide range of disciplines, such as Receptor, Somatic cell and Cancer immunotherapy.

His Adoptive cell transfer research includes elements of Cancer and Cancer research. His research in Cancer research intersects with topics in Sarcoma and NY-ESO-1. His studies in Internal medicine integrate themes in fields like Cytotoxic T cell and Surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cancer regression in patients after transfer of genetically engineered lymphocytes

Richard A. Morgan;Mark E. Dudley;John R. Wunderlich;Marybeth S. Hughes.
Science (2006)

3578 Citations

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

Mark E. Dudley;John R. Wunderlich;Paul F. Robbins;James C. Yang.
Science (2002)

3489 Citations

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Steven A. Rosenberg;James C. Yang;Douglas J. Schwartzentruber;Patrick Hwu.
Nature Medicine (1998)

2224 Citations

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy

Steven A. Rosenberg;James C. Yang;Richard M. Sherry;Udai S. Kammula.
Clinical Cancer Research (2011)

2198 Citations

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Mark E. Dudley;John R. Wunderlich;James C. Yang;Richard M. Sherry.
Journal of Clinical Oncology (2005)

1967 Citations

Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

Eric Tran;Simon Turcotte;Alena Gros;Paul F. Robbins.
Science (2014)

1898 Citations

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Paul F. Robbins;Richard A. Morgan;Steven A. Feldman;James C. Yang.
Journal of Clinical Oncology (2011)

1701 Citations

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.

Mojgan Ahmadzadeh;Laura A. Johnson;Bianca Heemskerk;John R. Wunderlich.
Blood (2009)

1634 Citations

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Mark E. Dudley;James C. Yang;Richard Sherry;Marybeth S. Hughes.
Journal of Clinical Oncology (2008)

1525 Citations

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

Laura A. Johnson;Richard A. Morgan;Mark E. Dudley;Lydie Cassard.
Blood (2009)

1514 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John R. Wunderlich

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 320

Nicholas P. Restifo

Nicholas P. Restifo

National Institutes of Health

Publications: 172

Carl H. June

Carl H. June

University of Pennsylvania

Publications: 130

Francesco M. Marincola

Francesco M. Marincola

National Institutes of Health

Publications: 117

Antoni Ribas

Antoni Ribas

University of California, Los Angeles

Publications: 98

Daniel E. Speiser

Daniel E. Speiser

University of Lausanne

Publications: 91

Richard A. Morgan

Richard A. Morgan

University of California, Los Angeles

Publications: 89

Gianpietro Dotti

Gianpietro Dotti

University of North Carolina at Chapel Hill

Publications: 88

George Coukos

George Coukos

University of Lausanne

Publications: 88

Michael H. Kershaw

Michael H. Kershaw

Peter MacCallum Cancer Centre

Publications: 87

Paul F. Robbins

Paul F. Robbins

National Institutes of Health

Publications: 87

Patrick Hwu

Patrick Hwu

The University of Texas MD Anderson Cancer Center

Publications: 84

Ton N. M. Schumacher

Ton N. M. Schumacher

Antoni van Leeuwenhoek Hospital

Publications: 82

Stanley R. Riddell

Stanley R. Riddell

University of Washington

Publications: 81

Phillip K. Darcy

Phillip K. Darcy

Peter MacCallum Cancer Centre

Publications: 80

Per thor Straten

Per thor Straten

University of Copenhagen

Publications: 77

Trending Scientists

Monson H. Hayes

Monson H. Hayes

George Mason University

Barbara Kitchenham

Barbara Kitchenham

Keele University

Ross Cutler

Ross Cutler

Microsoft (United States)

Ernst H. Oliw

Ernst H. Oliw

Uppsala University

Ernst Bauer

Ernst Bauer

TU Wien

Tjisse Hiemstra

Tjisse Hiemstra

Wageningen University & Research

Kirk T. Semple

Kirk T. Semple

Lancaster University

Minghui Hong

Minghui Hong

National University of Singapore

Jessica C. Kissinger

Jessica C. Kissinger

University of Georgia

Davide Cammarano

Davide Cammarano

Purdue University West Lafayette

Geoffrey W. Tregear

Geoffrey W. Tregear

University of Melbourne

Garry D. Honey

Garry D. Honey

Roche (Switzerland)

E. Paul Torrance

E. Paul Torrance

University of Georgia

Jeffrey T. Parsons

Jeffrey T. Parsons

City University of New York

Darrell W. Brann

Darrell W. Brann

Augusta University

Junichiro Makino

Junichiro Makino

Kobe University

Something went wrong. Please try again later.